Vivance
Singapore, Singapore· Est.
A med‑tech startup delivering portable, AI‑enabled peritoneal dialysis systems for CKD care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $20M
AI Company Overview
A med‑tech startup delivering portable, AI‑enabled peritoneal dialysis systems for CKD care.
Nephrology
Technology Platform
Sorbent‑based point‑of‑care dialysate generation combined with a wearable peritoneal dialysis device and AI‑driven remote monitoring platform.
Opportunities
Sustainable, home‑based dialysis can capture a growing CKD patient base and reduce healthcare costs, while AI‑enabled remote monitoring opens recurring‑service revenue streams.
Risk Factors
Regulatory approval timelines, reimbursement acceptance, and competition from established dialysis manufacturers could delay market entry.
Competitive Landscape
Vivance competes with traditional hemodialysis firms (Fresenius, Baxter) and emerging peritoneal platforms (Outset, NxStage), differentiating through portable sorbent‑based fluid generation and integrated digital health.